The request sought budget analysis on the revenue forgone in relation to the cost of negative gearing and the capital gains tax (CGT) discount. There are 2 components to this request: 

The request sought budget analysis on the revenue forgone in relation to the cost of negative gearing and the capital gains tax (CGT) discount. There are 2 components to this request: 

The request sought budget analysis on the revenue forgone in relation to the cost of negative gearing and the capital gains tax (CGT) discount. There are 2 components to this request: 

The request sought budget analysis on the revenue forgone in relation to the cost of negative gearing and the capital gains tax (CGT) discount. There are 2 components to this request: 

The request sought budget analysis on the revenue forgone in relation to the cost of negative gearing and the capital gains tax (CGT) discount. There are 2 components to this request: 

The request sought budget analysis on the revenue forgone in relation to the cost of negative gearing and the capital gains tax (CGT) discount. There are 2 components to this request: 

The request for budget analysis sought:

The National Bowel Cancer Screening Program (NBCSP) offers free bowel cancer screening kits to eligible Australians. Individuals aged 45 to 49 can request a screening kit, while those aged 50 to 74 automatically receive one in the mail every 2 years

The proposal would extend the NBCSP as follows:

• Option 1 – extend full biennial screening available to individuals 50-74 to those aged 25-49.
• Option 2 – extend opt-in screening available to individuals 45-49 to those aged 25-44.

The proposal would be ongoing and commence on 1 July 2026.

The National Bowel Cancer Screening Program (NBCSP) offers free bowel cancer screening kits to eligible Australians. Individuals aged 45 to 49 can request a screening kit, while those aged 50 to 74 automatically receive one in the mail every 2 years

The proposal would extend the NBCSP as follows:

• Option 1 – extend full biennial screening available to individuals 50-74 to those aged 25-49.
• Option 2 – extend opt-in screening available to individuals 45-49 to those aged 25-44.

The proposal would be ongoing and commence on 1 July 2026.